Professor Testifies He Tipped Ex-SAC Manager Martoma

Law360, New York (January 17, 2014, 6:40 PM EST) -- Mathew Martoma received confidential details about an Alzheimer’s drug study from a then-University of Michigan professor, the professor testified Friday in Manhattan federal court in the insider trading case against the ex-SAC Capital Advisors LP portfolio manager.

Sidney Gilman, who chaired a safety committee overseeing trials on the experimental drug bapineuzumab, said he provided Martoma with information about the drug ahead of a July 2008 conference in which he announced the study results.

“I revealed information that was confidential about a clinical drug trial to Mathew...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.